Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SBC Medical Group Holdings (SBC) Common Equity (2023 - 2025)

SBC Medical Group Holdings (SBC) has disclosed Common Equity for 3 consecutive years, with $248.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Common Equity rose 20.66% year-over-year to $248.0 million, compared with a TTM value of $248.0 million through Sep 2025, up 20.66%, and an annual FY2024 reading of $195.0 million, up 35.61% over the prior year.
  • Common Equity was $248.0 million for Q3 2025 at SBC Medical Group Holdings, up from $244.7 million in the prior quarter.
  • Across five years, Common Equity topped out at $248.0 million in Q3 2025 and bottomed at $103.3 million in Q1 2023.
  • Average Common Equity over 3 years is $173.3 million, with a median of $160.7 million recorded in 2024.
  • The sharpest move saw Common Equity soared 67.62% in 2024, then grew 20.66% in 2025.
  • Year by year, Common Equity stood at $143.8 million in 2023, then soared by 35.61% to $195.0 million in 2024, then grew by 27.16% to $248.0 million in 2025.
  • Business Quant data shows Common Equity for SBC at $248.0 million in Q3 2025, $244.7 million in Q2 2025, and $226.3 million in Q1 2025.